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Abstract 
Palliative care is defined as a specialty of medicine that improves the quality of life of patients 
and family members facing a life-threatening illness, by providing early detection and prevention 
of pain, psychological, and other physical struggles. Patients diagnosed with diseases such as 
congestive heart failure or lung disease will face an ongoing list of problems that impacts their 
quality of life, yet most do not receive the proper tools to manage their disease until the last 
stages of their life. Implementing palliative care at the initial diagnosis of a chronic 
cardiothoracic disease improves precision of patient-centered goals, symptom management, and 
overall quality of life for the patient.  
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Implementing Palliative Care Pre-Cardiothoracic Transplant 
Cardiothoracic Diseases 
 The diagnosis of a chronic cardiothoracic disease such as congestive heart failure (CHF), 
or lung diseases like idiopathic pulmonary fibrosis (IPF) or chronic obstructive pulmonary 
disease (COPD), requires a patient to decide treatment options that often focus on life-prolonging 
measures, even cardiothoracic transplant. With the diagnosis of a chronic illness, medical 
specialties such as cardiology, pulmonology, and cardiothoracic surgery are immediately 
employed. Under most circumstances, palliative care is rarely integrated until the patient's status 
is deteriorating or there is a failure to thrive.  
 The World Health Organization (2018) defines palliative care as "an approach that 
improves the quality of life of patients and their families facing the problem associated with life-
threatening illness, through the prevention and relief of suffering by means of early identification 
and impeccable assessment and treatment of pain and other problems, physical, psychosocial and 
spiritual. Palliative care provides relief from pain and other symptoms, emphasizes advanced 
care planning and medical treatment based on patient wishes, and uses an interdisciplinary 
approach to address all needs of the patient and family. Palliative care is split into eight domains 
that focus on 'whole person care' that acknowledges nonmedical facets of suffering when 
diagnosed with a serious or life-threatening illness (Anderson, Frazer, & Schellinger, 2018). 
These domains ensure that a patient is taken care of physically, psychologically, socially, 
spiritually, culturally, ethically, and at the time of death, while simultaneously ensuring that all 
necessary medical specialties are involved in patient care.  
 Integrating palliative care at the initial diagnosis of a life-threatening cardiothoracic 
disease would allow treatment options to be based on patient-centered goals of care, focus on 
symptom management, and improve quality of life for the patient. Since heart failure impacts 
nearly 6 million people in the United States and remains one of the leadings causes of 
hospitalization and health care expenditures it is important to focus on heart failure and how 
these patients' lives will be impacted (Tanner, Fromme, & Goodlin, 2011).  
 In order to recommend an integrated care model for a patient with the diagnosis of a 
chronic disease, it is important to understand how symptoms will impact the patient, how 
symptoms can be managed, and what can be done to optimize a patient's quality of life based on 
their personal goals and the domains of palliative care.  
 
Congestive Heart Failure 
 Congestive heart failure is defined as the inability of the heart to keep up with the 
demands on it, with failure of the heart to pump blood with normal efficiency. The heart is then 
unable to provide adequate blood flow to organs such as the brain, kidneys, and liver. Heart 
disease and CHF are difficult illnesses due to their complex symptom burden. CHF symptoms 
include: dyspnea, cardiac asthma, poor blood circulation, edema, and enlargement of the heart 
that leads to weakness, decreased blood flow to accessory organs, dizziness, and a decrease in 
overall function. These symptoms prevent patients from performing daily activities as they once 
did and often times impacts quality of life.  
 
Lung Disease 
 Lung disease is defined as any problem in the lungs that prevents a patient from working 
properly, whether it may be an airway disease (chronic obstructive pulmonary disease), lung 
tissue disease (cystic fibrosis), or lung circulation disease (pulmonary hypertension). Symptoms 
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of lung disease often include: coughing, wheezing, frequent respiratory infections, fatigue, and 
poor blood circulation. Mozes (2017) reports from 1980 through 2014, more than 4.6 million 
Americans died from a range of chronic respiratory illnesses (Mozes, 2017). The risk of death 
from chronic respiratory diseases rose 31% over the past 35 years and nearly 7% of all deaths in 
America are due to chronic respiratory diseases (Mozes, 2017). Factors for the increased rates 
are multifactorial but the significant increase in rates suggests that greater attention be paid to 
lung diseases. Currently, lung transplant candidates are rarely referred to palliative care unless 
they are deemed ineligible for transplant. End of life care is often aggressive and not based on 
comfort (Colman, Singer, Barua, & Downar, 2015). 
 Commonly, palliative care is associated with hospice and dying. Physicians often make 
this assumption and postpone palliative care intervention as long as possible. However, the 
symptoms and statistics of chronic cardiothoracic disease suggest that integrating palliative care 
with cardiothoracic disease in its early stage is necessary as patients often have prolonged 
periods of stability between exacerbations of their symptoms (Tanner, Fromme, & Goodlin, 
2011). Integrating palliative care at the initial diagnosis of a chronic cardiothoracic disease 
improves precision of patient-centered goals, symptom management, and overall quality of life 
for the patient.  
 
Choices After Diagnosis 
 After being diagnosed with cardiovascular disease or idiopathic pulmonary fibrosis, for 
example, the patient and family is often overwhelmed with information and the potential 
treatment options following their diagnosis. Subsequent heart disease treatment options often 
include procedures such as coronary artery bypass graft, insertion of ICD pacemakers, 
ventricular assist devices, extracorpeal membrane oxygenation (ECMO), heart transplant or 
potentially the use of only medications such as beta-blockers or diuretics. These treatment 
options range from mild to highly aggressive depending on the condition and wishes of the 
patient and the family.   
 Lung disease follows a similar pattern of mild to aggressive treatment options. Common 
treatment options include breathing treatments and antioxidants to slow the rate of lung decline 
in hopes of improving symptoms such as dyspnea, hypoxia, and weakness. Although those 
treatments may postpone the rate at which lung disease progresses, "lung transplantation remains 
the only treatment for most non-malignant end-stage lung disease" with the transplant candidates 
carrying a high symptom burden physically and psychologically (Colman, Singer, Barua, & 
Downar, 2015).  
 Medical facilities traditionally recommend heart and lung transplantation when other 
medical treatments no longer help. Medical programs currently believe the right time to proceed 
with transplantation is when it is felt that the patient would live longer with a transplant than 
with the heart or lung disease. Although this seems intuitive we must consider the treatment 
imperative- "defined as the perceived need by physicians and patients to provide interventions. 
The treatment imperative is driven by physicians' desires to offer treatment and patients feeling 
bound to not refuse treatment" (Santivasi, Strand, Mueller, & Beckman, 2017). Doctors are 
required to honor the Hippocratic oath in their practice; to do no harm and to treat the ill to the 
best of one's ability. Physicians are educated and trained to save patients' lives. The quality of 
life may at some point be compromised at the cost of prolonging someone's life. Patients feel 
intrigued to try new experimental surgeries or treatments that are considered life-prolonging but 
often times forget their personal wishes and goals of care or are unaware of the side effects. 
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Physicians take their oath to save and heal, but they may forget that they should do what is best 
for the patient, which may or may not be performing surgery or providing life-prolonging 
treatment. Similar to the treatment imperative is the organ transplant imperative which is "the 
perceived obligation to proceed with transplant and avoid end-of-life planning even in situations 
where the patient is experiencing poor quality of life and low likelihood of meaningful survival" 
(Santivasi, Strand, Mueller, & Beckman, 2017). With considerations of the treatment and organ 
transplant imperatives, it is important to have conversations regarding goals of care with the 
patient and family. The conversation should not occur once and be forgotten about. Goals of care 
and expectations from the patient should be addressed at the initial diagnosis and continue as the 
patient progresses with their disease to ensure that treatment, or lack of treatment, is what is best 
for the patient.  
 
Chronicity of Disease 
 Cardiothoracic diseases are complex due to their chronic nature with a slow and steady 
decline in function. Patients dealing with a chronic, or life threatening illness will experience 
what Robin Rone (2011) refers to as the four components of pain, better explained in figure 5 
(Rome, Luminais, Bourgeois, & Blais, 2011). The four components include physical symptoms, 
anxiety over the time to come, interpersonal problems, and not accepting that death may be 
approaching. Patients dealing with heart failure face a shortened lifespan and a chronic decline in 
function that may not be visible until the onset of an acute exacerbation (Tanner, Fromme, & 
Goodlin, 2011). It is difficult to prepare for and treat these acute bouts of CHF or lung disease 
without palliative care and the advanced care planning the specialty provides. When an acute 
event occurs, sudden decisions by the patient or patient's family member are made during 
stressful periods. These decisions often do not focus on the patient's goals of care but only what 
is necessary in the moment. In these circumstances difficult decisions are often postponed to 
focus on the present medical issue.  
 Patients awaiting a transplant experience high levels of anxiety due to the uncertain 
amount of time on the organ donor list. The demand for organs far exceeds the supply, causing 
patients to be on waitlists for years potentially. As of October, 2018 the Gift of Life states 156 
Michigan residents are awaiting heart transplants and 99 Michigan residents are waiting for 
lungs. While waiting for a transplant, a patient's condition may wax and wane so it is important 
to address goals of care and patient wishes even before a transplant because patients may never 
reach the destination of a transplant. Discussing goals of care prior to transplant helps navigate 
the uncertain territory of the waitlist.  
 Patients should be guided to appreciate that certain life-sustaining measures such as 
extracorpeal cardiopulmonary life support (ECLS) are not life saving but life prolonging until the 
next option arrives. ECLS is a variation of cardiopulmonary bypass that maintains oxygenation 
for days to weeks in patients with life threatening respiratory or cardiac failure.  Patients may not 
understand they may not be guaranteed a transplant once placed on the list, and even if the 
patient receives a transplant, it may not be beneficial. Aggressive end of life care such as ECLS 
is associated with worse patient quality of life and higher rate of anxiety in bereaved family 
members (Colman, Singer, Barua, & Downar, 2015). Even when patients with idiopathic 
pulmonary fibrosis are not being considered for transplant, a high proportion die in the ICU, with 
relatively few are seen by a palliative care specialist.  
 Discussing goals of care and expectations of treatment prior to transplant helps medical 
providers and patients align their expectations and base treatment options accordingly to provide 
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a better understanding of the uncertain road associated with cardiothoracic disease and 
transplantation.  
 
Lack of Palliative Care Education 
 Patients often experience unclear expectations when a cardiothoracic transplant is 
suggested as mentioned above. Time on the waitlist may take a toll on the patient and their 
family. However, even when the relief of palliative care (PC) is offered when the patient begins 
their chronic deterioration, a negative connotation is associated with the term. Palliative care is 
too closely associated with hospice and dying in today's society. When a patient or family 
member hears the suggestion of palliative care, they immediately associate the term with hospice 
and dying in the near future, or do not know what PC entails. Figure 2 evaluates how aware 
consumers are of the term palliative care; 92% are unfamiliar with the actual purpose of PC. It 
should be made clear that palliative care and hospice are separate specialties of medicine with 
similar goals including improving and, or maintaining the patient's quality of life (QOL).  
 Barriers to early evaluation of care preferences in lung transplant patients include the 
perception that these discussions would disqualify patients from disease-directed therapies. With 
this in mind, some providers and patients believe that PC is incompatible with transplantation 
and that palliative treatments should be held until the patient's final hours to not ruin the chance 
for transplant (Santivasi, Stand, Mueller, & Beckman, 2017). Physician focus groups showed 
that physicians are often very hesitant to recommend palliative care as anything other than "end 
of life care" or "comfort care", which would technically be considered hospice care, even though 
physicians are not making this distinction (McInturff, Harrington, 2011). A survey of transplant 
centers also indicated that patients believed if they engaged in palliative care they would feel 
abandoned, or that their quality of care would be insufficient (Santivasi, Stand, Mueller, & 
Beckman, 2017). In addition, patients expressed a concern with opioid dependency in association 
with palliative care, although this has been proven not to be an issue (Colman, Singer, Barua, & 
Downar, 2015). The lack of palliative care education amongst patients and providers alike makes 
it difficult to suggest palliative care as a method of improving quality of life. Thus, an issue is 
created where a trigger event must occur in order to initiate palliative care when the patient is in 
their final stages of life, "perpetuating the false dichotomy of palliative care versus (rather than 
palliative care plus) life-prolonging therapy" (Kavalieratos et al., 2017).  It has been suggested 
that using different terms when describing palliative care may be beneficial. For example, using 
terms such as 'serious illness' instead of 'terminal illness' gives the patient hope that there is still 
opportunity in the face of chronic illness. Education plays a large role in the acceptance and 
integration of palliative care into everyday medicine. Quality of life can be improved for both 
patients and families with a better understanding of palliative care.  
 
General Benefits/ Purpose of Palliative Care 
 Palliative care is an interdisciplinary approach and clinical subspecialty that focuses on 
improving QOL and reducing suffering experienced among patients with serious illness and their 
families (Kavalieratos et al., 2017). To be clear, quality of life is the concept used when 
discussing the implications of a serious medical condition. Doctors, family members, and others 
can have an opinion on the patient's quality of life, but only the patient themselves are able to 
truly determine their quality of life and what it would look like. One person may only care to be 
self-sufficient as long as possible, while another may want to walk their daughter down the aisle 
and be happy with whatever happens subsequent to that event. Each person has different goals 
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and this makes quality of life multidimensional and very personal. Quality of life considers 
physical, social, psychological, and spiritual wellbeing ("Quality of Life," 2012). Symptom 
burden heavily dictates quality of life. To understand the magnitude of heart failure, it has been 
stated that "advanced heart failure patients face a symptom burden comparable to that of 
advanced cancer patients" (Tanner, Fromme, & Goodlin, 2011).  
Management of Complex Symptom Burden. Palliative care puts emphasis on symptom 
and pain management through medications and therapies that primary physicians would often not 
consider. PC is able to manage complex symptom burden experienced by chronic heart and lung 
disease patients. LVAD patients experience bleeding, infection, device thrombosis, and 
cerebrovascular events that can negatively impact their QOL and place a large burden on family 
members, physically and psychologically. Joint Commission and Centers for Medicare and 
Medicaid Services (CMS) determined that PC should be incorporated into LVAD destination 
therapy (Nakagawa, Yuzefpolskaya, Colombo, Naka, & Blinderman, 2017). Patients in end-stage 
lung disease awaiting transplant experience physical, psychological, and emotional symptoms 
including dyspnea, cough, anxiety, depression, and insomnia (Freeman et al., 2016). The 
integrative approach PC provides would help manage symptoms and propose new ways to treat 
complex symptoms.  
 Economic Relief. Along with the physical and psychological stress heart failure and lung 
disease place on patients and families, there is also a large financial burden associated with these 
diseases. Heart failure management places a large financial burden on families, health care 
systems and society. Dio Kavalieratos states that "direct medical costs of HF are projected to be 
>$77 billion by 2030, a 215% increase from current spending" (Kavalieratos et al., 2017). In 
part, the massive expense can be attributed to recurring hospital admission associated with lack 
of advanced care planning in HF and lung disease patients. Although doctors and patients tend to 
avoid end of life (EOL) conversations and the possibility of death, patients who did engage in 
these conversations had enhanced hope (Nakagawa, Yuzefpolskaya, Colombo, Naka, & 
Blinderman, 2017). Patients who expressed their wishes under PC support would be able to 
minimize unncecessary hospitalizations, thus decreasing costs and excess stress.  
 Improved Patient Outcomes. Palliative care is able to manage a complex symptom 
burden associated with heart failure and lung disease, as well as improve patient outcomes. A 
2010 study reported that lung cancer patients receiving early palliative care had less depression, 
improved quality of life, and survived 2.7 months longer (Center to Advance Palliative Care). A 
large proportion of end-stage lung disease patients (lung transplant candidates and recipients in 
particular) die in a critical care environment, receiving aggressive care that is not focused on 
comfort (Colman, Singer, Barua, & Downar, 2015). Palliative care would help to direct the 
patient's medical care in the direction the patient and family deemed best. Institutions such as the 
American College of Chest Physicians (ACCP) and American Thoracic Society (ATS) have both 
emphasized the importance of palliative and end of life care (EOLC) for symptomatic patients 
with pulmonary disease at any stage of illness (Colman, Singer, Barua, & Downar, 2015).  
 
When to Begin Palliative Care 
 Introducing the topic of palliative care and the conversation of advanced care planning is 
often one of the more difficult tasks doctors admit to in their practice, quite possibly a reason 
palliative care is underutilized. New studies have suggested that the best way to manage heart 
failure symptoms is to treat the underlying heart failure condition (e.g., relieving dyspnea by 
addressing fluid overload) (Kavalieratos et al., 2017). The approach mentioned is an example of 
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how heart failure and palliative care can interface in the early stages of a diagnosis to help 
alleviate a patient's symptom burden and worries of their disease. At the initial diagnosis of heart 
or lung disease, prognostication should be used to have clear algorithms and checklist in place to 
manage care following diagnosis and determine if a patient is ready for a cardiothoracic 
transplant. Included on the initial checklist should be the consult of palliative care. In this 
manner, the PC team is able to meet with the patient, discuss goals of care, possible treatment 
plans reflecting those goals or care, and support to patients deciding if cardiothoracic transplant 
is in the patient's best interest. The use of such checklists could alleviate the transplant 
imperative, unnecessary stress, and hospital visits for the patient.  
 In addition to using checklists and algorithms to standardize when patients should begin 
palliative care, PC has shifted to outpatient consultations that would allow early integration of 
services. Outpatient clinics suggest that a patient is still battling with a disease, but symptoms 
have not progressed far enough to require hospitalization; this timing provides "an ideal 
opportunity to integrate palliative care into a transplant program" (Wentlandt et al., 2016) The 
patient and family member may feel less overwhelmed outside of a hospital where they feel they 
may be dying. Outpatient palliative care consultations allow clear conversations to be made, with 
the intent of advanced care planning and discussion of the realistic options ahead 
 The Transplant Palliative Care Clinic (TPCC) in Toronto, Canada is an outpatient clinic 
that takes patients with any advanced disease as evaluated by the transplant program, and 
performs palliative care consults with no limitation on prognosis, status on the waiting list, or 
being pre- or post-transplantation (Wentlandt et al., 2016). The initial consultation lasts about 60-
90 minutes, includes a chart review, history, and assessment. Additionally, a symptom 
assessment survey is completed at each appointment, with additional referrals being made as 
necessary. The TPCC is allowing patients to have a patient- centered care plan that manages 
symptoms and allows an integrative approach to be made regardless of the patient's progression 
in their disease. The patient's status on the wait list is not compromised because of their PC 
assistance as patients and physicians often fear- the only difference is the patient's QOL is 
improved with palliative care consultations (Wentlandt et al., 2016). Figure 3 suggests starting 
palliative care at the initial diagnosis and tailoring the patient's treatment to fit their goals, which 
may change as the disease progresses. Table 1 provides insight into the timing related to 
referring a patient to primary palliative care, or specialized palliative care resources. Primary PC 
should be initiated at the initial diagnosis of cardiothoracic disease and as symptoms progress as 
shown in the table, specialized care can be escalated (Kavalieratos et al., 2017).  
 
Integration of Palliative Care 
 Saying that palliative care is important and worthy is not enough. The challenge remains 
in how PC is integrated, and how it will supplement chronic disease and/or a potential 
cardiothoracic transplant. Accepting the outlook that palliative care is 'preparedness planning' for 
patients who are focused on improving shifts the connotation away from dying. It has been 
suggested by Dr. Craig Tanner that preparedness planning should be proposed at the initial 
diagnosis of heart failure (Tanner, Fromme, & Goodlin, 2011). In an effort to do this, palliative 
care has been integrated in outpatient clinics, as mentioned previously. Additionally, 
interdisciplinary primary care models for older adults with chronic illnesses are now of particular 
interest. Four features of a care model trialed by Washington University's Care Coordination 
Program included: comprehensive assessment of the patient's health conditions, treatments, 
behaviors, risks, supports and resources, evidence-based care planning and monitoring to meet 
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the patient's health related needs and preferences, promotion of patients' and family caregivers' 
active engagement in care, and coordination and communication among all professionals 
engaged in a patient's care (McCarthy, Ryan & Klein, 2015). Integrating a care model of this 
nature offers to achieve the "triple aim" that reduces costs while improving the patient's health 
and care experiences. A high need patient in this context would be a chronic or terminal illness 
patient with either CHF, IPF, or lung cancer with high costs associated with frequent hospital 
readmissions due to a lack of care planning or proper expectations of potential outcomes 
following procedures such as an LVAD or cardiothoracic transplant.  
 If palliative care were to intervene earlier in these high-risk, high-cost patients’ 
diagnoses, the extra resources could be placed in improving their QOL and decrease costs, 
allowing a return on investment (ROI) that palliative care provides. The average cost for one 
night of treatment in an intensive care unit is $4000 (Winters, 2013). With palliative care on-
boarded, there is potential to minimize these admissions with advanced care planning. Tables 2-5 
highlight the chance of hospital admissions with PC. The results are not significant. However, 
clinical trials with PC are still novel, leaving promise for future growth.  
 Similar to a checklist at the time of diagnosis, several doctors trialed a pre-VAD 
evaluation for patients in destination therapy (would use device until death) or those with bridge 
to transplantation. The pre-VAD evaluation "aimed to test the feasibility of PC intervention to 
elucidate patients’ goals and values in LVAD therapy in both destination therapy (DT) and 
bridge to transplant (BTT)" ((Nakagawa, Yuzefpolskaya, Colombo, Naka, & Blinderman, 2017). 
The palliative care evaluation was mandatory and addressed patient comfort, patient and family 
understanding of LVAD therapy, patient goals and expectations, spiritual needs, possible 
complications and unacceptable conditions, as well as decision making. After the evaluation, 
family awareness of acceptable conditions for a patient increased from 33% to 58%, being 
statistically significant, p< 0.01 ((Nakagawa, Yuzefpolskaya, Colombo, Naka, & Blinderman, 
2017). Another study found similar results, finding that after a PC consultation, six patients 
requested their resuscitation orders be changed from full code to DNR (Colman, Singer, Barua, 
& Downar, 2015). Knowledge of effective palliative care routes made some patients realize their 
goals could be achieved without life-prolonging measures and treatments. Facilities utilizing 
palliative care on a regular basis report that integration of palliative care prior to ventricular 
assist device placement can help prepare patients and families for the difficult process of 
discontinuing VAD support (Colman, Singer, Barua, & Downar, 2015). These studies 
demonstrate that early intervention through consultations and evaluations help patients identify 
their desires in the face of illness as well as reduce emotional and financial stress as difficult 
decisions arise later in the course of illness.  
 
Destination with Early Palliative Care 
 Clinical trials implementing palliative care in the early stages of heart and lung disease 
are scarce because the research is still new. The lack of education and push towards the treatment 
imperative make it difficult for patients and physicians to accept palliative care, but the studies 
that do integrate palliative care early in a patient's treatment plan are promising and show 
statistical significance. The Palliative Care in Heart Failure (PAL-HF) clinical trial provided an 
interdisciplinary palliative care intervention in advanced HF patients that consistently showed 
greater benefits to QOL, anxiety, depression, and spiritual well-being compared to usual care 
alone. A study performed in 2010 determined patients assigned to early PC had fewer depressive 
symptoms (p=0.001) compared to standard care patients and the median survival was longer 
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amongst PC patients as well (p=0.002) (Temel et al., 2010). Temel (2010) reports data in figure 4 
indicating that early palliative care intervention increased life expectancy by an average of 3 
months. Sidebottom (2014) found similar results in her study where QOL scores increased 12.92 
points in the intervention compared to 8 points in the control group that did not receive PC 
intervention (p<0.001) (Sidebottom, Jorgenson, Richards, Kirven, & Sillah, 2014). Symptom 
burden between test subjects and controls also had statistical significance (p<0.001) (Sidebottom, 
Jorgenson, Richards, Kirven, & Sillah, 2014). Kavalieratos (2017) reports findings from a 2015 
trial that compared the impact of inpatient consultation by a palliative care team versus usual 
care for patients hospitalized for acute HF. Data suggest statistically significant improvements 
for patients receiving inpatient PC consultations, including QOL, symptom burden, and mood" 
(Kavalieratos et al., 2017). Studies such as they indicate the benefit of integrating palliative care 
early in a patient's diagnosis. 
 A common misconception about palliative care and symptom management include the 
prescription of opioids and benzodiazepines for symptom management. Both physicians and lung 
transplant candidates often avoid such medications due to concern that they may compromise a 
patient's eligibility for transplant (Colman, Singer, Barua, & Downar, 2015). However, several 
clinical trials determined that "there were no episodes of clinically important opioid toxicity or 
respiratory depression, and there was a trend toward increased exertion during exercise sessions 
post-opioid versus pre-opioid" (Colman, Singer, Barua, & Downar, 2015), suggesting that 
opioids prescribed to alleviate symptoms may improve quality of life without compromising 
transplant eligibility. From a retrospective cohort study, 8 lung transplant recipients (33%) co-
managed with palliative care did not receive CPR at the time of death, as dictated by palliative 
care planning (Colman, Singer, Barua, & Downar, 2014). Small details such as these may seem 
insignificant. However, it is shown that when patient's wishes at the time of death were honored 
the bereavement of family members was improved (Anderson et al., 2018). Family members are 
able to reflect on their loved one's legacy and find solace in knowing their wishes were honored. 
 Although physicians are reluctant to integrate palliative care into their patient's care, 
"heart failure/ transplant team physicians who requested assistance with symptom management, 
clarification of goals of care, and end-of-life care, viewed PC integration as beneficial to the 
patient. Improved efficiency of HF/ transplant team was reported" (Schwarz et al., 2012). 
Palliative care consultations and intervention helped dying lung transplant patients avoid 
aggressive care and the ICU environment at the end of life (Colman, Singer, Barua, & Downar, 
2015). By limiting the number of ICU visits, family members decrease the excessive cost of 
hospitalizations, as well as the uncertain stress hospitals place on families and patients. Palliative 
care may seem to be an additional cost, but there is a return on investment when considering 
unnecessary medical treatment. For example, "patients enrolled in Medicaid at 4 New York state 
hospitals who received palliative care incurred $6,900 less in hospital costs than a matched group 
receiving usual care (Center to Advance Palliative Care). Palliative care consultations in another 
study done by CAPC resulted in reductions of $1,700 in direct costs per admission for live 
discharges and $4,900 per admission when the patient died in the hospital (Morrison et al., 
2008). When the costs are extrapolated, the result is a saving of more than $1.3 million for a 
small hospital, and $2.5 million for an average sized medical center. Cost analysis of early 
palliative care integration is still underdeveloped with complex interactions between costs of care 
and diagnosis (e.g. cancer/ non-cancer distinctions) but these numbers show promise towards 
reducing costs in an aging population (Smith, Brick, O'Hara, & Normand, 2014). Integrating 
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palliative care early may also reduce costs by reducing the number of hospital admissions. 
Further research is required to determine exact cost savings. 
 Palliative care is designed to look at a patient in the most holistic sense with domains 
currently categorized into the following groups: spiritual, social, psychological, physical, ethical, 
cultural, end of life aspects. These categories focus on goals of care that best influence the 
patient, family, and potentially the health care system with the reduction of costs and high-risk 
patients within hospital settings. Potential lies in adding a financial and legacy/bereavement 
domain to the field, as they are already goals that lie within the principles of palliative care. The 
goal of integrating palliative care at an early stage encompasses these ideas and allows a smooth 
transition through arguably the most daunting time in a patient's life. Palliative care aids in 
allowing the dying process to seem more normal. Families are able to better prepare for death of 
their loved one knowing their wishes were met, and a plan was in place. Palliative care focuses 
on these ideals and the domains to improve the precision of patient-centered goals, symptom 
management, and overall quality of life for the patient.  
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Tables/ Figures 
 
Figure 1. Demonstrating the waxing and waning condition of a heart failure patient awaiting a 
transplant (Bayoumi, Sheikh, & Groninger, 2017). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Consumer Awareness About Palliative Care. Approximately 92% of consumers in the 
health care industry either misunderstood, or did not understand the purpose of palliative care. 
With greater education, the distinction between palliative care and hospice can be made and 
quality of life of many could be improved (McInturff, Harrington, 2011).  
 
 
3 2011 Public Opinion Research on Palliative Care 
 
Key Finding:  
 
This research confirms palliative care is a relative unknown among consumers.   
 
There s a clear n ed to inform consumers about p lliative care and provid  consumers with a
definition of palliative care.  
 
Consumer Awareness About Palliative Care 
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Figure 3. Suggested time to initiate palliative care and how palliative care will progress through 
the remainder of the patient's life (Kirch, 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Kaplan- Meier Estimates of Survival According to Study Group. Median estimates of survival 
were as follows: 9.8 months in the entire sample (151 patients), 11.6 months in the group assigned to 
early palliative care (77 patients), and 8.9 months in the standard care group (Temel et al, 2010). 
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Figure 5. Symptoms experienced by patients diagnosed with a chronic or terminal illness that 
may or may not be dying (Rome, Luminais, Bourgeois, & Blais, 2011). 
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Table 1. Primary Palliative Care Versus Specialty Palliative Care for Patients with Heart Failure 
and Their Families. Criteria for when to refer to primary palliative care versus specialty 
palliative care (Kavalieratos et al., 2017). 
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Table 2. Summary of Existing Trials of Inpatient Specialty Palliative Care in Heart Failure. 
Results from previously performed clinical trials implementing PC in HF (Kavalieratos et al., 
2017). 
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Table 3. Summary of Existing Trials of Outpatient Specialty Palliative Care in HF. (Kavalieratos 
et al., 2017) 
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Table 4. Summary of Existing Trials of Home-Based Specialty Palliative Care in HF. 
(Kavalieratos et al., 2017) 
 
 
 
 
Table 5. Summary of Existing Trials of Primary Palliative Care/Collaborative Care Models in 
HF. (Kavalieratos et al., 2017) 
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